About
This medication is a combination oral antidiabetic agent containing Glimepiride and Metformin, specifically designed for the management of type 2 diabetes mellitus in adults. Glimepiride, a sulfonylurea, works by stimulating the pancreatic beta cells to release insulin, thereby lowering blood glucose levels. This action is particularly effective in reducing fasting and post-meal glucose. Metformin, a biguanide, primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues, leading to enhanced glucose uptake and utilization by muscles. This dual mechanism of action effectively addresses both impaired insulin secretion and insulin resistance, which are key underlying issues in type 2 diabetes. It is typically prescribed for adult patients whose blood sugar levels are not adequately controlled by monotherapy with either Glimepiride or Metformin alone, or as an initial therapy in certain cases where a combined approach is deemed necessary. The combination helps achieve better glycemic control and reduces the risk of long-term diabetes complications.
Uses
- Management of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- When monotherapy with Glimepiride or Metformin is insufficient.
- As an adjunct to diet and exercise.
Directions For Use
Take orally with meals, as directed by your physician, usually with breakfast or the first main meal to minimize gastrointestinal side effects.
Benefits
- Dual mechanism of action for effective blood sugar control.
- Reduces both fasting and post-meal glucose levels.
- Improves insulin sensitivity and secretion.
- Helps achieve target HbA1c levels.
- May contribute to weight stability or modest weight loss (Metformin effect).
- Reduces the risk of diabetes-related complications.
Side Effects
- Hypoglycemia (low blood sugar)
- Nausea
- Diarrhea
- Abdominal pain/discomfort
- Metallic taste
- Headache
- Dizziness
- Weight gain (Glimepiride effect)
- Skin rash
- Lactic acidosis (rare, serious with Metformin)
- Vitamin B12 deficiency (with Metformin)
- Flatulence
Safety Measures
- Alcohol - Avoid excessive alcohol consumption due to increased risk of hypoglycemia and potential for lactic acidosis with Metformin.
- Pregnancy - Generally not recommended during pregnancy. Insulin therapy is usually preferred for glycemic control in pregnant women with diabetes.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and affect the infant.
- Liver - Contraindicated in severe liver impairment due to increased risk of lactic acidosis (Metformin) and altered drug metabolism. Use with caution in mild to moderate cases.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to Metformin accumulation and increased risk of lactic acidosis. Dose adjustment required for moderate impairment.
- Lung - Use with caution in conditions causing hypoxia (e.g., severe respiratory failure) as it may increase the risk of lactic acidosis with Metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!